AIM
DRIO icon

Acrospire Investment Management’s DarioHealth DRIO Stock Holding History

Acrospire Investment Management’s Portfolio DRIO Stock Details DRIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-2
Closed -$2K – 2245
2017
Q1 		$2K Buy
+2
New +$2.97K ﹤0.01% 2107

Other funds holding DRIO

BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
PVH
Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Acrospire Investment Management's DRIO Position: Q2 2017 in Review

Acrospire Investment Management sold out of DarioHealth (DRIO) in Q2 2017, closing a stake of 2 shares — an estimated $2K sold.

Acrospire Investment Management first reported a position in DRIO in Q1 2017 and held it in 1 quarter. The position peaked at $2K in Q1 2017. 10 funds tracked by Wall St. Rank hold DRIO as of Q2 2017.

  • Acrospire Investment Management reported no remaining DarioHealth position as of Q2 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 2 DarioHealth shares in Q2 2017, an estimated $2K.
  • Acrospire Investment Management first reported a position in DarioHealth in Q1 2017 and held it in 1 quarter.
  • Acrospire Investment Management's DarioHealth position peaked at $2K in Q1 2017.
  • 10 funds tracked by Wall St. Rank held DarioHealth as of Q2 2017.

Based on Acrospire Investment Management's 13F filing for Q2 2017, filed 11 Aug 2017.